764
T. Sixt, W. Kaim / Inorganica Chimica Acta 300–302 (2000) 762–768
3
lic hydroxyl group neigbouring the benzylideneimino
function. The structural and chemical activity of the
non-chelating hydroxyl substituent of the Bim(OH)O
anionic ligand will be particularly addressed. The
DipaH3 ligand serves as model for the fully reduced
form of TPQ (Fig. 1) but may also be written as the
iminol tautomer [21] in the deprotonated form.
4-OH), 8.16 (d, 2H, J=7.5 Hz), 7.71–7.53 (m, 3H,
H-3%/H-4%/H-5%), 7.10 (d, 1H, H-6, J=8.6 Hz), 6.25 (dd,
3
4
1H, H-5, J=8.6 Hz, J=2.5 Hz), 6.31 (m, 1H, H-3).
3.1.2. 4-Nitroso-6-isobutylresorcinol
An amount of 400 mg (2.41 mmol) 4-isobutylresor-
cinol [24] was dissolved in 15 ml HCl-saturated ethanol.
Slow addition at −5°C of 166 mg (2.41 mmol) NaNO2
in 1 ml H2O produced an ochre-coloured precipitate
which was collected by filtration, washed with water
and dried under vacuum (280 mg, 59%). 1H NMR
(acetone-d6): l 0.88 (d, 6H, C(CH3)2, 3J=6.6 Hz), 1.83
(sept, 1H, CH(CH3)2, 3J=6.6 Hz), 2.26 (d, 2H,
As to the copper(I) complex fragment (PPh3)2Cu+,
previous results for complexes with N,O-donor ligands,
including those with biochemical relevance, have shown
that the phosphine co-ligands stabilize the CuI oxida-
tion state and facilitate crystallization [7b,22,23].
3
PhꢀCH2ꢀ, J=6.9 Hz,), 2.85 (s, br, OH), 5.71 (s, 1H,
phenyl), 7.35 (s, 1H, phenyl), 8.94 (s, br, 1-OH), 12.31
(s, br, 3-OH).
2. Experimental
2.1. Instrumentation
3.1.3. N-(2,4-Dihydroxy-5-isopropylphenyl)acetamide
(DipaH3)
NMR spectra were taken on Bruker AC 250 or AC
400 spectrometers, infrared spectra were obtained using
a Perkin–Elmer Paragon 1000 PC instrument. UV–
Vis/NIR absorption spectra were recorded on a Bruins
Instruments Omega 10 spectrophotometer. Cyclic
voltammetry was carried out at 100 mV s−1 standard
scan rate in dichloromethane/0.1 M Bu4NPF6 using
a three-electrode configuration (glassy carbon elec-
trode, Pt counter electrode, Ag/AgCl reference) and
a PAR 273 potentiostat and function generator.
The decamethylferrocene–decamethylferrocenium cou-
ple served as internal reference, potentials are given in
V versus ferrocene–ferrocenium (DE=0.55 V).
A suspension of 100 mg (0.51 mmol) 4-nitroso-6-
isobutylresorcinol and 15 mg Pd/C in 2 ml acetic acid
and 1 ml acetic anhydride was treated with 0.1 bar
H2/0.9 bar Ar for 20 min. Filtration over celite, reduc-
tion to dryness, treatment with chloroform in an ultra-
sonic bath and drying under vacuum gave 82 mg (73%)
1
of a colourless residue. H NMR (CD3OD): l 0.88 (d,
3
3
6H, J=6.6 Hz, CH(CH3)2), 1.84 (sept, 1H, J=6.6
Hz, CHCH3)2), 2.13 (s, 3H, C(O)CH3), 2.35 (d, 2H,
3J=6.6 Hz, ꢀCH2ꢀ), 6.34 (s, 1H, H-3), 6.95 (s, 1H,
1
H-6); H NMR (acetone-d6): l 0.86 (d, 6H, CH(CH3)2,
3J=6.6 Hz), 1.87 (sept, 1H, CHCH3)2, J=6.6 Hz),
3
2.15 (s, 3H, C(O)CH3), 2.35 (d, 2H, ꢀCH2ꢀ, J=7.13
Hz), 6.39 (s, 1H, H-3), 6.80 (s, 1H, H-6), 8.00 (s,
exchangeable with MeOD), 9.20 (s, br, exchangeable
with MeOD), 9.37 (s, exchangeable with MeOD). 13C
NMR (CD3OD): l 22.82 (C(O)CH3), 22.95 (CH(CH3),
29.96 (CH(CH3), 39.82 (ꢀCH2ꢀ), 104.89 (C-3), 118.44
(C-1), 120.84 (C-5), 126.87 (C-6), 149.34 (C-2), 155.10
(C-4), 172.18 (C(O)CH3).
3. Syntheses
3.1. Ligands
3.1.1. (4-Benzylideneamino)resorcinol hydrochloride
Bim(OH)2·HCl
A suspension of 500 mg (3.1 mmol) 4-aminoresor-
cinol hydrochloride (Aldrich) and 1 ml (9.8 mmol)
benzaldehyde in 30 ml acetonitrile was treated with
methanol until a homogeneous mixture had formed.
Stirring overnight and reduction of the volume to 5 ml
gave a yellowish precipitate which was dried to yield
3.2. Complexes
3.2.1. [(BimO)Cu(PPh3)2]
A
suspension of 164 mg (0.253 mmol)
Cu(PPh3)(NO3) [25] in 5 ml methanol was treated with
50 mg (0.253 mmol) 2-benzylideneaminophenol [20]
and 2.5 ml of 0.1 N H3CONa/CH3OH in 5 ml CH3OH.
After clearing, the volume of the solution was reduced
to yield 145 mg (73%) of an orange–red precipitate.
Anal. Calc. for C49H40CuNOP2 (784.36 g mol−1): C,
73.35; H, 5.28; N, 1.75. Found: C, 73.31; H, 5.41; N,
1
675 mg (87%) of the product. H NMR (acetone-d6): l
3
10.05 (s, 1H, NꢁCH), 7.91 (d, 2H, H2%/H6%, J=7.5
Hz), 7.69–7.61 (m, 3H, H3%/H4%/H5%), 7.10 (d, 1H, H6,
3J=8.7 Hz), 6.88 (d, 1H, H3, J=2.5 Hz), 6.47 (dd,
3
5
1
1H, J=8.5 Hz, J=2.5 Hz); H NMR (DMSO-d6),
closed form: l N···HꢀO: 10.01 (s, 1H, NꢁCH), 9.60 (s,
br, 4-OH), 8.98 (s, br, 1H, N···HꢀO), 8.16 (d, 2H,
3J=7.5 Hz), 7.71–7.53 (m, 3H, H-3%/H-4%/H-5%), 7.34
1
1.76%. H NMR (acetone-d6): l 8.73 (s, 1H, NꢁCHꢀ),
3
8.01 (d, 1H, H2%/H6%, J=7.5 Hz), 7.18–7.36 (m, 2H,
3
3
(d, 1H, H-6, J=8.6 Hz), 6.34 (dd, 1H, H-5, J=8.6
Hz, 4J=2.5 Hz), 6.31 (m, 1H, H-3); open form: l 10.50
(s, br, 1H, 2-OH···N), 10.01 (s, 1H, NꢁCH), 9.60 (s, br,
H3%/H4%/H5%), 6.86 (m, 2H, H-4/H-5), 6.64 (d, 1H, H-6,
3J=8.6 Hz), 6.17 (t, 1H, H-3, J=7.3 Hz). 31P NMR
3
(CDCl3): l −2.27 ppm.